1. Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery
    Niels J. van Ruitenbeek et al, 2021, Journal of Neuro-Oncology CrossRef
  2. Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth
    Xuanhao Li et al, 2019, Cellular Signalling CrossRef
  3. Synthesis and anticancer effects of α-lipoic ester of alloxanthoxyletin
    Wioletta Olejarz et al, 2019, Medicinal Chemistry Research CrossRef
  4. Identification of key gene signatures and their characterization by expression correlation with drug sensitivity in smoking-associated oral squamous cell carcinoma
    Pavan Gollapalli et al, 2023, Journal of Cancer Research and Therapeutics CrossRef
  5. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1—NFκB—IL-6 signalling axis
    Ethan L. Morgan et al, 2019, PLOS Pathogens CrossRef
  6. Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
    Rachel A. O’Keefe et al, 2020, PLOS ONE CrossRef
  7. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
    Nirmala Chandralega Kampan et al, 2017, Frontiers in Immunology CrossRef
  8. Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns
    Nikita Aggarwal et al, 2020, Frontiers in Cellular and Infection Microbiology CrossRef
  9. circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
    Qing Lv et al, 2022, Genetics Research CrossRef
  10. Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer
    Stuti Biswal et al, 2023, Archives of Oral Biology CrossRef
  11. Honey activity on the proliferation and migration of oral squamous cell carcinoma: In vitro and bioinformatic analysis
    Macedo Sobrinho Santos Eliane et al, 2018, Scientific Research and Essays CrossRef
  12. Interleukin-6, C/EBP-β and PPAR-γ expression correlates with intramuscular liposarcoma growth in mice: The impact of voluntary physical activity levels
    Mohamad Assi et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  13. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma
    Song Xu et al, 2018, Thoracic Cancer CrossRef
  14. The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer
    Clarence T. Sasaki et al, 2020, Oral Oncology CrossRef

  15. Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma


    Yanping Ji et al, 2020, OncoTargets and Therapy CrossRef
  16. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma
    Gregory B. Lesinski et al, 2019, Head and Neck Pathology CrossRef
  17. Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells
    Mohammed L. Ibrahim et al, 2020, Cancer Immunology, Immunotherapy CrossRef
  18. Pleiotropic Effects of Epithelial Mesenchymal Crosstalk on Head and Neck Cancer: EMT and beyond
    T. B. Steinbichler et al, 2019, Cancer Microenvironment CrossRef
  19. Emission Factors of CO2 and Airborne Pollutants and Toxicological Potency of Biofuels for Airplane Transport: A Preliminary Assessment
    Maurizio Gualtieri et al, 2022, Toxics CrossRef
  20. Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Daniel E. Johnson et al, 2018, Nature Reviews Clinical Oncology CrossRef
  21. IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
    L.P. Stabile et al, 2017, Oral Oncology CrossRef
  22. Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion
    Haaglim Cho et al, 2018, Clinical Cancer Research CrossRef
  23. Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review
    Fatemeh Atashi et al, 2021, Journal of Dental Research, Dental Clinics, Dental Prospects CrossRef
  24. Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival
    Ling-Ying Wei et al, 2022, Oral Oncology CrossRef
  25. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts
    Barbora Peltanova et al, 2021, International Journal of Molecular Sciences CrossRef
  26. IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives
    Michal Španko et al, 2021, International Journal of Molecular Sciences CrossRef
  27. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance
    Kevin Dzobo et al, 2020, OMICS: A Journal of Integrative Biology CrossRef
  28. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression
    Jian Gao et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
  29. Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer
    Jennifer A. Bridge et al, 2018, Frontiers in Medicine CrossRef
  30. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
    Ethan L. Morgan et al, 2020, Viruses CrossRef
  31. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles
    Helene Hersvik Aarstad et al, 2020, Biomedicines CrossRef
  32. Photoelectrochemical immunoassay for human interleukin 6 based on the use of perovskite-type LaFeO3 nanoparticles on fluorine-doped tin oxide glass
    Xing-Pei Liu et al, 2018, Microchimica Acta CrossRef
  33. Jak/STAT Signaling in Head and Neck Cancer
    Elizabeth Cedars et al, 2018, Molecular Determinants of Head and Neck Cancer CrossRef
  34. Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma
    Bowen Yang et al, 2019, Frontiers in Oncology CrossRef
  35. Suppression of TLR signaling by IRAK-1 and -4 dual inhibitor decreases TPF-resistance-induced pro-oncogenic effects in HNSCC
    Humayara Khan et al, 2023, 3 Biotech CrossRef
  36. Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC
    Julia Meidenbauer et al, 2024, Frontiers in Oncology CrossRef
  37. Is it the time to study air pollution effects under environmental conditions? A case study to support the shift of in vitro toxicology from the bench to the field
    Maurizio Gualtieri et al, 2018, Chemosphere CrossRef
  38. Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
    Gene Chatman Clark et al, 2022, Frontiers in Oncology CrossRef
  39. Identification of Potential Candidate Genes of Oral Cancer in Response to Chronic Infection With Porphyromonas gingivalis Using Bioinformatical Analyses
    Fengxue Geng et al, 2019, Frontiers in Oncology CrossRef
  40. Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD‐L1
    Pei Zhang et al, 2018, Cancer Medicine CrossRef
  41. Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
    Yixiao Qin et al, 2021, Molecular Therapy - Oncolytics CrossRef
  42. The intersection of COVID-19 and cancer: signaling pathways and treatment implications
    Zhi Zong et al, 2021, Molecular Cancer CrossRef
  43. Autocrine IL-6 drives cell and extracellular matrix anisotropy in scar fibroblasts
    Fiona N. Kenny et al, 2023, Matrix Biology CrossRef
  44. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
    Eva A. Ebbing et al, 2019, Proceedings of the National Academy of Sciences CrossRef
  45. Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Uzdan Uz et al, 2021, Clinical and Experimental Otorhinolaryngology CrossRef
  46. CCDC68 Upregulation by IL-6 Promotes Endometrial Carcinoma Progression
    Xuqing Li et al, 2021, Journal of Interferon & Cytokine Research CrossRef
  47. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
    Venus Dalal et al, 2018, Clinica Chimica Acta CrossRef
  48. Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells
    Tao Jia et al, 2020, Archives of Oral Biology CrossRef
  49. Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?
    Ethan L. Morgan et al, 2020, Cancers CrossRef
  50. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
    Yunseo Woo et al, 2020, Cells CrossRef
  51. Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
    Till Jasper Meyer et al, 2021, International Journal of Molecular Sciences CrossRef
  52. Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial
    Alexander Rühle et al, 2022, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
  53. Localized delivery of Erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma
    Kartik Hariharan et al, 2023, International Journal of Pharmaceutics CrossRef
  54. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression
    Xiao-Long Fu et al, 2017, Cancer Immunology, Immunotherapy CrossRef